WHO recommendations for influenza virus vaccine composition for the 2018 southern hemisphere influenza season
The World Health Organization (WHO) has recommended the composition of the trivalent influenza vaccine for the southern hemisphere winter 2018 influenza season in a report published 28 September 2017.
Diphtheria outbreaks in Yemen and Venezuela
An outbreak of diphtheria is currently being experienced in Yemen and Venezuela. One hundred and twenty diphtheria cases have been reported in Yemen in the last two months, while Venezuela has seen more than 500 probable cases in 2017, as detailed in today’s Communicable Disease Threat Report.
Low uptake of seasonal influenza vaccination in Europe may jeopardise capacity to protect people in next pandemic
Influenza vaccination coverage among high-risk groups has dropped in the European Region over the last seven years, and half the countries report a decrease in the number of vaccine doses available.
Workshop: Influenza vaccination campaigns of healthcare workers
The uptake of seasonal influenza vaccination in EU Member States has not reached the target levels in the 2009 Council Recommendations. This knowledge sharing workshop is intended to support communications activities surrounding national influenza vaccination campaigns, specifically campaigns targeting healthcare workers. The workshop will highlight good practices and success stories, as well as share encouraging and challenging experiences of the Member States’ campaigns. It will also discuss and consider ways ECDC can support Member States in their campaigns through the creation of a “community of practice”, and how best to achieve that via the existing platforms and tools.
WHO recommendations for influenza virus vaccine composition for the 2015 southern hemisphere season
The World Health Organization (WHO) ha.s agreed on the recommended composition of the trivalent influenza vaccine for the southern hemisphere winter 2015 influenza season.
Update on narcolepsy cases associated with Pandemrix vaccination in 2009 in the Netherlands
In November 2014, the Pharmacovigilance Centre of Netherlands (Lareb) provided an updated overview of Dutch cases of narcolepsy reported to have a link to Pandemrix.
Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2
This new publication from Novartis in collaboration with public health and academic researchers in Finland and the US adds to the evidence-base on how narcolepsy might have been triggered in genetically susceptible individuals.